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Background: Bacterial resistance to commonly used antimi-
crobial agents is growing up day by day in both community
and hospital settings.Therefore this study was initiated to bench-
mark prevailing resistance rates for the most common bacterial
pathogens in PED of Specialized Pediatric Hospital aiming to be
able to design local data- based antibiotic policy.
Methods&Materials: A cross sectional study performedon970
patients selected from 1085 cases admitted to PED from August
2011–August 2012. All specimens were collected, processed, cul-
tured and the isolates were identiﬁed according to the standard
microbiological techniques. AST of all isolates was determined fol-
lowing the performance standards set by CLSI.
Results: Pneumonia cases were the commonest (79%). The pre-
dominant pathogen in pneumoniawas pseudomonas (27.7%), while
CONS (42.9%) and E.coli (63.6%) were the most prevalent in sep-
sis and UTI respectively. Methicillin resistance was encountered
in 75% of Staphylococci aureus and 99% of CONS isolates. All E-
coli (100%) and 73% of Klebsiella spp. strains exhibited phenotypic
ESBL patterns. Antibiotic sensitivity pattern in pneumonia was;
ciproﬂoxacin 43.4%, imipenem 42.3% and meropenem 37% in Gram
negative organisms, while Gram positive organisms showed 100%
sensitivity to vancomycin, teicoplanin, clindamycin and erythro-
mycin and 66% to doxycycline. In sepsis; Gram negative organisms
were sensitive to: ciproﬂoxacin 67%, aztreonam 53.6%, gentamycin
41.3%, imepenem40.6%, and amikacin 36% andGrampositive orga-
nisms were 100% sensitive to vancomycin, 86.5% to teicoplanin
and 42.5% to clindamycin. Gram negative organisms isolated from
patients with UTI showed highest sensitivity to: ciproﬂoxacin
83.3%, meropenem 44.3% and amikacin 25%, while Gram positive
organisms were 100% sensitive to vancomycin and gentamycin.
Conclusion: Alarming increase in MDR organisms, enhanc-
ing demands to review strictly the infection control measures to
limit development and spread of bacterial resistance. Establish-
ment of antibiotic policy guided by the collected data in our study,
which is updatedperiodically according tomicrobiology laboratory
reports to monitor variations in pathogen occurrences and emerg-
ing antimicrobial resistance, especially because a new agents such
as ﬂuoroquinolones are recently used to a greater extent in this age
group.
http://dx.doi.org/10.1016/j.ijid.2014.03.1280
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Background: Currently there is an ongoing debate and a dearth
of evidence on the selection of masks and respirators for the pre-
vention of respiratory infections in HCWs. The aim of this study
was to explore the recommendations around the facemask use in
the national guidelines in low/middle income countries.
Methods & Materials: A cross sectional survey was conducted
in China, Pakistan and Vietnam. A range of health and infectious
disease stakeholders were invited to participate. The survey was
completed via face to face interviews. Three diseases were selected
for this study; inﬂuenza (including seasonal, avian and pandemic
inﬂuenza), SARS and TB.
Results: In all three countries surveyed, recommendations
regarding the use of masks/respirators are captured in both gen-
eral and disease speciﬁc infection control guidelines. In Pakistan
and China, the guidelines were developed in line with WHO and
CDC recommendations and participants from Vietnam highlighted
that their guidelines are in line with the WHO recommendations
only.
While the guidelines from both Pakistan and China discuss
at length the use of masks/respirators, only the Chinese policy
includes information regarding the regulation over use and certiﬁ-
cation processes for respirators. All guidelines document the need
for training and ﬁt testing; however no system exists to monitor
the training and ﬁt testing programs in three countries.
Therewas someconsistency in regards to the typesofmasks rec-
ommended for inﬂuenza, SARS and TB. Various types of facemasks
(paper mask, cloth mask, surgical masks and respirators) are rec-
ommended for routine care in three countries; however surgical
masks and respirators are the preferred options during high risk
situations. The description of what constitutes a low and high risk
situation also varied in the guidelines. Extended use of facemasks
is not recommended in the Chinese and Vietnamese guidelines;
however, participants in Pakistan indicated that extended use is
suggested. Even though the practice is common, the reuse ofmasks
after decontamination is not recommended in any guideline.
Conclusion: There is a need to examine the available evidence
and develop a comprehensive policy on the use of facemasks in
various respiratory infections. The policy should address critical
areas, like regulation, training and ﬁt testing.
http://dx.doi.org/10.1016/j.ijid.2014.03.1281
